4.6 Review

Research progress on the relationship between the TOR signaling pathway regulator, epigenetics, and tumor development

期刊

FRONTIERS IN GENETICS
卷 13, 期 -, 页码 -

出版社

FRONTIERS MEDIA SA
DOI: 10.3389/fgene.2022.1006936

关键词

TOR signaling pathway regulator; protein phosphatase; cancer; epigenetic; metabolism

资金

  1. Ningbo Health Branding Subject Fund [PPXK 2018-05]
  2. Natural Science Foundation of Ningbo [2019A610225]
  3. Hwamei Fund [2019HMZDKY04, 2022HMKY37]
  4. Key discipline of Hwamei Hospital, University of Chinese Academy of Science [2020ZDXK03]
  5. Medical Health Science and Technology Project of Zhejiang Provincial Health Commission [2021KY1009, 2022KY1138]

向作者/读者索取更多资源

Protein phosphorylation/dephosphorylation is an important regulatory mechanism for controlling cellular processes, and alterations in phosphorylation networks have major implications in diseases, including cancer. TOR signaling pathway and TIPRL play crucial roles in the cell cycle and their dysregulation may contribute to tumorigenesis. This review aims to provide comprehensive insights into the role of TIPRL in cancer development, as well as the TIPRL/PP2A axis and its epigenetic regulation.
Almost all cellular activities depend on protein folding, signaling complex assembly/disassembly, and epigenetic regulation. One of the most important regulatory mechanisms responsible for controlling these cellular processes is dynamic protein phosphorylation/dephosphorylation. Alterations in phosphorylation networks have major consequences in the form of disorders, including cancer. Many signaling cascades, including the target of rapamycin (TOR) signaling, are important participants in the cell cycle, and dysregulation in their phosphorylation/dephosphorylation status has been linked to malignancies. As a TOR signaling regulator, protein phosphatase 2A (PP2A) is responsible for most of the phosphatase activities inside the cells. On the other hand, TOR signaling pathway regulator (TIPRL) is an essential PP2A inhibitory protein. Many other physiological roles have also been suggested for TIPRL, such as modulation of TOR pathways, apoptosis, and cell proliferation. It is also reported that TIPRL was increased in various carcinomas, including non-small-cell lung carcinoma (NSCLC) and hepatocellular carcinomas (HCC). Considering the function of PP2A as a tumor suppressor and also the effect of the TIPRL/PP2A axis on apoptosis and proliferation of cancer cells, this review aims to provide a complete view of the role of TIPRL in cancer development in addition to describing TIPRL/PP2A axis and its epigenetic regulation.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据